Deaths From Viral Hepatitis Are on the Rise
“Viral hepatitis is now the second leading infectious cause of death globally after tuberculosis, the World Health Organization’s report reveals. Viral hepatitis testing and treatment coverage rates have stalled despite improved diagnostic and treatment tools and decreasing product prices, according to the report released at the World Hepatitis Summit.”
Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant
“SINGAPORE, April 15, 2024 /PRNewswire/ — Gilead Sciences, Inc. (Nasdaq: GILD), announced a global distribution of US$4 million through its ALL4LIVER Grant (“Grant”) to support community-backed innovative projects associated with hepatitis B (HBV), hepatitis C (HCV), and hepatitis D (HDV) in conjunction with the World Hepatitis Summit (“Summit”).”
Canada Set to Miss WHO Hepatitis C Elimination Goal: Study
“Canada will not reach the original World Health Organization’s (WHO) target of eliminating the Hepatitis C virus (HCV) by 2030 and lags in comparison to other developed countries, a new study led by researchers at the University of Waterloo has found.”
Half of People With Hepatitis Are Scared to Share Their Diagnosis
“Half of Europeans living with hepatitis B (HBV) or hepatitis C (HCV) struggle to share their diagnosis with others due to stigma, according to a multicountry study presented at the World Hepatitis Summit.”
Video:
